The Minister of Health, Aaron Motsoaledi, welcomed the support, saying it strengthened the country's HIV response ...
Tribune News Service on MSNOpinion
Commentary: Trump’s dangerous war on drugs
In recent weeks, the Trump administration has waged war on suspected drug smugglers in the waters off Venezuela, blowing up ...
China has donated $3.5 million to support South Africa's HIV/AIDS prevention and control efforts among youths, a key group of HIV infections, ahead of the G20 Leaders' Summit.
China has announced a US$3.49 million (R60 million) partnership with South Africa to expand HIV prevention services among adolescents and young people, as ...
Bayer’s Hyrnuo gets US FDA accelerated approval to treat patients with previously treated advanced HER2-mutant NSCLC: Berlin Friday, November 21, 2025, 11:00 Hrs [IST] Following ...
The U.S. just shipped two million doses of lenacapavir, a groundbreaking twice-a-year HIV-prevention injectable medication, ...
The American Legion Post 159 made a $1,000 donation to the Belmont County Schools Staying Clean program at the Belmont County ...
Patient advocacy groups urged the South African government to issue a compulsory license for a groundbreaking HIV prevention ...
Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, ...
The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...
Merck reports positive results from phase 3 trial of once-daily, oral, two-drug, single-tablet regimen of Doravirine/Islatravir in treatment-naïve adults with HIV-1 infection ...
Clinical Trials Arena on MSN
MSD’s once-daily HIV pill non-inferior to Biktarvy in Phase III trial
MSD announced the data just days after Gilead also touted success with a once-daily antiretroviral therapy (ART).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results